Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin add-on to metformin and sitagliptin in type 2 diabetes mellitus
2013-004819-40Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Canagliflozin add-on arm with Placebo add-on arm (2 arms). Primary endpoint: Change from baseline in glycosylated hemoglobin. Started Feb 2014; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-004819-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004819-40.